Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through the nationwide connectivity of Quest Diagnostics, equipping clinicians with access to blood-based screening innovation for colorectal cancer (CRC) through one of the largest … [Read more...] about Guardant Health’s Shield Blood-Based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
Guardant Health
As April Marks National Cancer Prevention and Early Detection Month, FDA-Approved Blood Test for Colorectal Cancer Screening Makes It Easier to Screen in Nevada
Innovative Testing Option Proven to Close Nevada’s Screening Gap by Making it Easier for Patients to Get Screened for Colorectal Cancer In recognition of National Cancer Prevention and Early Detection Month, a time dedicated to raising awareness about the importance of preventive screening and early detection, a new, innovative blood test for colorectal cancer is transforming … [Read more...] about As April Marks National Cancer Prevention and Early Detection Month, FDA-Approved Blood Test for Colorectal Cancer Screening Makes It Easier to Screen in Nevada